Tandem Diabetes Care (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes Care (NASDAQ: TNDM) reported Q3 EPS of ($0.85), $0.03 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.6 million.

For earnings history and earnings-related data on Tandem Diabetes Care (TNDM) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Toro (TTC) PT Lowered to $115 at DA Davidson
• StoneX on Mama’s Creations (MAMA): 'We Remain High-Conviction Buyers'